CIK 0001314102 · Non-accelerated filer<br>Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262774444
- Phone
- 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $52,258
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$52,258. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-02 | Lurker Nancy Director | Gift · Stock Option (Right to Buy) | +15,278 | 31,944 | ||
| 2025-07-02 | Lurker Nancy Director | Gift · Stock Option (Right to Buy) | −27,270 | 49,730 | ||
| 2025-07-02 | Lurker Nancy Director | Gift · Stock Option (Right to Buy) | +27,270 | 27,270 | ||
| 2025-06-23 | Duker Jay S. President and CEO | Other disposition | −56,665 | $8.21 | $465K | 986 |
| 2025-05-25 | Elston George Chief Financial Officer | Option exercise | +7,500 | 83,050 | ||
| 2025-05-25 | Elston George Chief Financial Officer | Shares withheld for taxes | −2,202 | $5.68 | $13K | 80,848 |
| 2025-05-25 | Elston George Chief Financial Officer | Option exercise · Restricted Stock Units | −7,500 | 7,500 | ||
| 2025-05-19 | Zaderej Karen L. Director | Purchase | +5,000 | $5.99 | $30K | 36,500 |
| 2025-05-16 | Zaderej Karen L. Director | Purchase | +5,000 | $5.81 | $29K | 31,500 |
| 2025-05-15 | Zaderej Karen L. Director | Purchase | +5,000 | $5.47 | $27K | 26,500 |
| 2025-05-14 | Zaderej Karen L. Director | Purchase | +5,000 | $5.42 | $27K | 21,500 |
| 2025-03-19 | Duker Jay S. President and CEO | Other disposition | −20,000 | $6.16 | $123K | 57,651 |
| 2025-02-09 | Elston George Chief Financial Officer | Option exercise | +5,834 | 75,550 | ||
| 2025-02-09 | Elston George Chief Financial Officer | Option exercise · Restricted Stock Units | −5,834 | 0 | ||
| 2025-02-09 | Lurker Nancy Director | Option exercise | +20,000 | 205,436 | ||
| 2025-02-09 | Lurker Nancy Director | Option exercise · Restricted Stock Units | −20,000 | 0 | ||
| 2025-02-09 | Duker Jay S. President and CEO | Option exercise | +7,000 | 79,706 | ||
| 2025-02-09 | Duker Jay S. President and CEO | Shares withheld for taxes | −2,055 | $6.50 | $13K | 77,651 |
| 2025-02-09 | Duker Jay S. President and CEO | Option exercise · Restricted Stock Units | −7,000 | 0 | ||
| 2025-01-08 | Sanders Reginald J. Director | Grant or award · Stock Options (Right to buy) | +80,000 | 80,000 |
Page 6 of 18 · 352 trades